生物技术公司Aardvark Therapeutics(股票代码为：“AARD”）昨日在美国纳斯达克上市。 Aardvark Therapeutics发行价为16美元，发行588.8万股，募资总额为9421万 ...

While Aardvark Therapeutics is interested in serving this market, first it wants to validate its approach by treating patients whose excessive eating is rooted in a rare genetic disorder.